Abstract
BACKGROUND: Stroke presents a significant economic burden worldwide, with the impact being especially pronounced in developing countries. China is currently implementing Diagnosis-Related Group (DRG) reforms, attempting to use more traditional Chinese medicine (TCM) modalities to alleviate the economic burden on stroke patients. METHODS: This retrospective study extracted the medical records of stroke inpatients at Qingyang City Hospital of TCM from 2017 to 2022 from China's Gansu National Health Big Data Platform. A single-group interrupted time series (ITS) design was employed to assess the impact of DRG reform on patients' hospitalization costs and length of stay (LOS). Additionally, a two-group ITS was utilized to evaluate treatment costs and medicine costs. RESULTS: The single-group ITS analysis indicated that the average LOS decreased by 0.06 days per month following the reform (P < 0.05), while the average hospitalization cost declined by 48.92 yuan per month (P < 0.05). The two-group ITS results revealed a significant reduction in the average monthly cost of Western medicine by 22.67 yuan post-reform (P < 0.05), whereas the average monthly cost of Chinese medicine increased by 2.93 yuan, though this change was not statistically significant (P > 0.05). Additionally, the average monthly cost of Western medical treatment decreased by 11.24 yuan (P < 0.05). Acupuncture and massage treatment costs exhibited an initial sharp increase followed by a downward trend, with an average monthly decrease of 9.53 yuan (P < 0.05). CONCLUSION: DRG reduced hospitalization costs and shortened the LOS of stroke patients, which may be related to the increased use of TCM in stroke treatment.